Search research articles
Contact Us
Filters
Showing results (821-830 of 839) with videos related to
Page
of 84
Sort By:
Leukemia & Lymphoma
|
July 28, 2012
Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemia
Yvette L Kasamon, Robert A Brodsky, Michael J Borowitz, et al.
Leukemia Research
|
July 6, 2010
Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSF
B Douglas Smith, Richard J Jones, Eunpi Cho, et al.
Leukemia
|
October 14, 2014
SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS
D Inoue, J Kitaura, H Matsui, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 22, 2018
Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation
Yvette L Kasamon, Ephraim J Fuchs, Marianna Zahurak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 23, 2017
Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide
Shannon R McCurdy, Christopher G Kanakry, Hua-Ling Tsai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 18, 2015
Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA Factors
Jennifer A Kanakry, Christopher D Gocke, Javier Bolaños-Meade, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 2, 2019
Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide
Shannon R McCurdy, Christopher G Kanakry, Hua-Ling Tsai, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
Rapaprotin is Activated by an Endopeptidase to Disassemble 26S Proteasome
Hanjing Peng, Zufeng Guo, Wei Li Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 30, 2017
Major Histocompatibility Mismatch and Donor Choice for Second Allogeneic Bone Marrow Transplantation
Philip H Imus, Amanda L Blackford, Maria Bettinotti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 18, 2018
Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not Outcomes
Shannon R McCurdy, Stephen T Muth, Hua-Ling Tsai, et al.
Page
of 84
Search research articles
Search
Showing results (821-830 of 839) with videos related to
Sort By:
Page
of 84
Leukemia & Lymphoma
|
July 28, 2012
Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemia
Yvette L Kasamon, Robert A Brodsky, Michael J Borowitz, et al.
Leukemia Research
|
July 6, 2010
Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSF
B Douglas Smith, Richard J Jones, Eunpi Cho, et al.
Leukemia
|
October 14, 2014
SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS
D Inoue, J Kitaura, H Matsui, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 22, 2018
Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation
Yvette L Kasamon, Ephraim J Fuchs, Marianna Zahurak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 23, 2017
Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide
Shannon R McCurdy, Christopher G Kanakry, Hua-Ling Tsai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 18, 2015
Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA Factors
Jennifer A Kanakry, Christopher D Gocke, Javier Bolaños-Meade, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 2, 2019
Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide
Shannon R McCurdy, Christopher G Kanakry, Hua-Ling Tsai, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
Rapaprotin is Activated by an Endopeptidase to Disassemble 26S Proteasome
Hanjing Peng, Zufeng Guo, Wei Li Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 30, 2017
Major Histocompatibility Mismatch and Donor Choice for Second Allogeneic Bone Marrow Transplantation
Philip H Imus, Amanda L Blackford, Maria Bettinotti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 18, 2018
Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not Outcomes
Shannon R McCurdy, Stephen T Muth, Hua-Ling Tsai, et al.
Page
of 84